Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

New antiasthma agents reported by Sandoz

Jan. 24, 1997

New alpha1-adrenoceptor antagonists from Roche

Jan. 24, 1997

Eisai discloses IL-1 inhibitors

Jan. 23, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

5-HT3/5-HT4 receptor ligands disclosed by Synthelabo

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.